Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT04650607
Recruiting Observational

Phage Safety Cohort Study

NCT04650607 · tracked via the Priya Life Science France tracker
Sponsor
Hospices Civils de Lyon
Phase
Observational
Started
2022-05-09
Last updated
2023-04-13

Condition(s) studied

Prosthetic Joint InfectionSevere Infection

Investigational drug(s) / intervention(s)

Adverse event after injection of phages

Adverse event after injection of phages: rate and description of adverse event after injection of phages

Study summary

This cohort study aims to describe the adverse events related to the use of bacteriophages to treat serious infections, data from the literature being almost non-existent on this subject.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient 18 years of age or older with a serious infection treated at CRIOAc Lyon by phage therapy * Patient who did not object to participating in the study * Patients ayant un poids minimum de 46kg Exclusion Criteria: * Patients under guardianship/curatorship * Patients deprived of liberty * Pregnant or breastfeeding women

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospices Civils de Lyon Lyon France Recruiting

More Hospices Civils de Lyon trials in France

Study on Ventilation Distribution With Electrical Impedance Tomography for Paediatric Respiratory Failure Recruiting
Phenotyping Acute Non-Severe Anemia in the Emergency Department Starting soon
Impact of a Multi-infusion Strategy in Neonatology on the Rate of Central Line-associated Bloodstream Infections Recruiting
Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes Recruiting
Evaluation of Walking Analysis After a Total Knee Arthroplasty With Kinematic Alignment Versus Mechanical Alignment Recruiting

Other trials for the same condition

Prosthetic Joint Infection : Lessons From Deceased Patients in Critical Care. Recruiting
PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL. Recruiting
Study of the Lived Experience of Patients With Prosthetic Joint Infection, Their Families, and Healthcare Professionals. Development of a Therapeutic Education Program for Patient Care (TEP). Starting soon
CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit Recruiting
Cohort of Prosthetic Joint Infections Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04650607 on ClinicalTrials.gov ↗ ← All trials in France